Outcome of acute myeloid leukemia (AML) relapsing after autologous bone marrow transplantation (ABMT) in first remission.

被引：0
|
作者：
Vignetti, M
Iacopino, P
Trasarti, S
Messina, G
Barbui, T
Carella, AM
Alessandrino, PP
Benedetti, F
Falda, M
Sajeva, MT
Carlo-Stella, C
Lambertenghi, G
Sica, S
Visani, G
Meloni, G
机构：
来源：
BONE MARROW TRANSPLANTATION | 1998年 / 21卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
13
引用
收藏
页码：S4 / S4
页数：1
相关论文
共 50 条
  • [41] Autologous bone marrow transplantation (ABMT) using 4-hydroperoxycyclophosphamide (4HC) purging for acute myeloid leukemia (AML) beyond first remission: A ten-year experience.
    Smith, BD
    Jones, RJ
    Piantadosi, S
    Lee, SM
    Vala, MS
    Gore, SD
    Noga, SJ
    Miller, CB
    BLOOD, 1998, 92 (10) : 323A - 323A
  • [42] The source of stem cells does not affect the outcome of patients undergoing autologous stem cell transplantation for acute myeloid leukemia in first remission.
    Reiffers, J
    Labopin, M
    Sanz, M
    Korbling, M
    Marit, G
    delaRubia, J
    Haas, R
    Blaise, D
    Gorin, NC
    BLOOD, 1996, 88 (10) : 2724 - 2724
  • [43] AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN ACUTE MYELOID-LEUKEMIA IN RELAPSE OR IN COMPLETE REMISSION
    HERVE, P
    ROZENBAUM, A
    PLOUVIER, E
    FLESCH, M
    CAHN, JY
    FARRADJI, A
    BERGERAT, JP
    ADJIZIAN, JC
    PIGNON, B
    CANCER TREATMENT REPORTS, 1982, 66 (11): : 1983 - 1985
  • [44] MAINTENANCE OF REMISSION IN ACUTE MYELOID-LEUKEMIA BY ALLOGENIC OR AUTOLOGOUS BONE-MARROW TRANSPLANTATION
    BEELEN, DW
    QUABECK, K
    MAHMOUD, HK
    SAYER, HG
    KRAFT, J
    GRAEVEN, U
    GROSSEWILDE, H
    QUAST, U
    SCHAEFER, UW
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1991, 116 (11) : 401 - 410
  • [45] MYELOABLATIVE THERAPY WITH AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) AS CONSOLIDATION OF 1ST REMISSION IN YOUNGER PATIENTS WITH ACUTE MYELOGENOUS LEUKEMIA (AML)
    ROHATINER, AZS
    BASSAN, R
    BATTISTA, R
    WHELAN, JS
    JOHNSON, PWM
    AMESS, JAL
    ARNOTT, SJ
    BURINI, G
    PERSONENI, A
    CARTER, M
    BARBUI, T
    LISTER, TA
    BLOOD, 1993, 82 (10) : A192 - A192
  • [46] LOW-DOSE IL-2 DURING 6 MONTHS AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) FOR ACUTE MYELOID-LEUKEMIA (AML)
    FALKENBURG, JHF
    HOOFTMANDENOTTER, A
    VANDERELSHOUT, M
    VANDERMAREL, A
    KLUINNELEMANS, JC
    SCHAAFSMA, MR
    FIBBE, WE
    BRANDELY, M
    WILLEMZE, R
    EXPERIMENTAL HEMATOLOGY, 1993, 21 (08) : 1119 - 1119
  • [47] Idarubicin to intensify the conditioning regimens of autologous bone marrow transplantation for patients with acute myeloid leukemia in first complete remission
    Sh Jerjis
    E Roovers
    P Muus
    N Schaap
    T de Witte
    Bone Marrow Transplantation, 1998, 22 : 13 - 19
  • [48] Idarubicin to intensify the conditioning regimens of autologous bone marrow transplantation for patients with acute myeloid leukemia in first complete remission
    Jerjis, S
    Roovers, E
    Muus, P
    Schaap, N
    de Witte, T
    BONE MARROW TRANSPLANTATION, 1998, 22 (01) : 13 - 19
  • [49] AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR ACUTE MYELOID-LEUKEMIA IN FIRST REMISSION - IDENTIFICATION OF MODIFIABLE PROGNOSTIC FACTORS
    MEHTA, J
    POWLES, R
    SINGHAL, S
    HORTON, C
    TAIT, D
    MILAN, S
    MELLER, S
    PINKERTON, CR
    TRELEAVEN, J
    BONE MARROW TRANSPLANTATION, 1995, 16 (04) : 499 - 506
  • [50] Idarubicin to intensify the conditioning regimens of autologous bone marrow transplantation for patients with acute myeloid leukemia in first complete remission
    Jerjis, S
    Roovers, E
    Muus, P
    Schaap, N
    de Witte, T
    BONE MARROW TRANSPLANTATION, 1998, 21 : S99 - S99
12345